Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Multiple Sclerosis

Free Subscription Articles published in J Neurol Retrieve available abstracts of 116 articles: HTML format Text format

Single Articles

March 2010
1. OGUZ KK , Kurne A, Aksu AO, Taskiran A, et al
   A comparative assessment of cerebral white matter by magnetization transfer imaging in early- and adult-onset multiple sclerosis patients matched for disease duration.
   J Neurol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. YALDIZLI O , Atefy R, Gass A, Sturm D, et al
   Corpus callosum index and long-term disability in multiple sclerosis patients.
   J Neurol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
3. STRUPP M
   Multiple sclerosis: transformation, freedom and clarity for our patients?
   J Neurol. 2010.
   PubMed     Text format     Related articles   
   
   
   
4. IGNACIO RJ , Liliana P, Edgardo C
   Oligoclonal bands and MRI in clinically isolated syndromes: predicting conversion time to multiple sclerosis.
   J Neurol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. STEFFENSEN LH , Mellgren SI, Kampman MT
   Erratum to: Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis.
   J Neurol. 2010.
   PubMed     Text format     Related articles   
   
   
   
6. HENDERSON AP , Trip SA, Schlottmann PG, Altmann DR, et al
   A preliminary longitudinal study of the retinal nerve fiber layer in progressive multiple sclerosis.
   J Neurol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
7. SIMMONS RD , Tribe KL, McDonald EA
   Living with multiple sclerosis: longitudinal changes in employment and the importance of symptom management.
   J Neurol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. SADIQ SA , Puccio LM, Brydon EW
   JCV detection in multiple sclerosis patients treated with natalizumab.
   J Neurol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   November 2009
9. GOLDACRE MJ , Duncan M, Griffith M, Turner MR, et al
   Trends in death certification for multiple sclerosis, motor neuron disease, Parkinson's disease and epilepsy in English populations 1979-2006.
   J Neurol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. HELLWIG K , Haghikia A, Gold R
    Parenthood and immunomodulation in patients with multiple sclerosis.
    J Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. HARTUNG HP , Aktas O, Kieseier B, Comi G, et al
    Development of oral cladribine for the treatment of multiple sclerosis.
    J Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. JONGEN PJ , Sindic C, Carton H, Zwanikken C, et al
    Improvement of health-related quality of life in relapsing remitting multiple sclerosis patients after 2 years of treatment with intramuscular interferon-beta-1a.
    J Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. AKTAS O , Hartung HP
    Neuromyelitis and more: the unfolding spectrum of aquaporin 4-related neurological diseases.
    J Neurol. 2009;256:1906-8.
    PubMed     Text format     Related articles   
    
    
    October 2009
14. HOLMOY T , Kampman MT
    Alaska, multiple sclerosis, and the vitamin D hypothesis.
    J Neurol. 2009.
    PubMed     Text format     Related articles   
    
    
    
15. PRESSLAUER S , Milosavljevic D, Brucke T, Bayer P, et al
    Erratum to: Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis.
    J Neurol. 2009.
    PubMed     Text format     Related articles   
    
    
    
16. RAMAGOPALAN SV , Dyment DA, Guimond C, Orton SM, et al
    Mother-child blood group incompatibility and the risk of multiple sclerosis.
    J Neurol. 2009.
    PubMed     Text format     Related articles   
    
    
    
17. STEFFENSEN LH , Mellgren SI, Kampman MT
    Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis.
    J Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
18. HOLPER L , Coenen M, Weise A, Stucki G, et al
    Characterization of functioning in multiple sclerosis using the ICF.
    J Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. STARCK M , Albrecht H, Pollmann W, Dieterich M, et al
    Acquired pendular nystagmus in multiple sclerosis: an examiner-blind cross-over treatment study of memantine and gabapentin.
    J Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
20. POHL D , Rostasy K, Jacobi C, Lange P, et al
    Intrathecal antibody production against Epstein-Barr and other neurotropic viruses in pediatric and adult onset multiple sclerosis.
    J Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. UZAWA A , Mori M, Ito M, Uchida T, et al
    Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis.
    J Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
22. STOSIC M , Ambrus J, Garg N, Weinstock-Guttman B, et al
    MRI characteristics of patients with antiphospholipid syndrome and multiple sclerosis.
    J Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. SPANEVELLO RM , Mazzanti CM, Bagatini M, Correa M, et al
    Activities of the enzymes that hydrolyze adenine nucleotides in platelets from multiple sclerosis patients.
    J Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. ISMAIL A , Kemp J, Sharrack B
    Melanoma complicating treatment with Natalizumab (Tysabri) for multiple sclerosis.
    J Neurol. 2009.
    PubMed     Text format     Related articles   
    
    
    
25. FERNANDEZ O , R-Antiguedad A, Pinto-Medel MJ, Mendibe MM, et al
    HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain).
    J Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. MESSMER UCCELLI M , Specchia C, Battaglia MA, Miller DM, et al
    Factors that influence the employment status of people with multiple sclerosis: a multi-national study.
    J Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. SOLARO C , Boehmker M, Tanganelli P
    Pregabalin for treating paroxysmal painful symptoms in multiple sclerosis: a pilot study.
    J Neurol. 2009.
    PubMed     Text format     Related articles   
    
    
    
28. MOWRY EM , Pesic M, Grimes B, Deen SR, et al
    Clinical predictors of early second event in patients with clinically isolated syndrome.
    J Neurol. 2009;256:1061-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
29. DEBETTE S , de Seze J, Pruvo JP, Zephir H, et al
    Long-term outcome of acute and subacute myelopathies.
    J Neurol. 2009;256:980-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
30. HUTCHINSON M , Kappos L, Calabresi PA, Confavreux C, et al
    The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL.
    J Neurol. 2009.
    PubMed     Text format     Related articles   
    
    
    
31. MASSA J , O'Reilly E, Munger KL, Delorenze GN, et al
    Serum uric acid and risk of multiple sclerosis.
    J Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
32. PIERROT-DESEILLIGNY C
    Clinical implications of a possible role of vitamin D in multiple sclerosis.
    J Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. WALLIN MT , Page WF, Kurtzke JF
    Migration and multiple sclerosis in Alaskan military veterans.
    J Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. LANGE R , Volkmer M, Heesen C, Liepert J, et al
    Modafinil effects in multiple sclerosis patients with fatigue.
    J Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. PITTAS F , Ponsonby AL, van der Mei IA, Taylor BV, et al
    Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis.
    J Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. GRASSIOT B , Desgranges B, Eustache F, Defer G, et al
    Quantification and clinical relevance of brain atrophy in multiple sclerosis: a review.
    J Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. JOHNSON FR , Van Houtven G, Ozdemir S, Hass S, et al
    Multiple sclerosis patients' benefit-risk preferences: serious adverse event risks versus treatment efficacy.
    J Neurol. 2009;256:554-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. TREADAWAY K , Cutter G, Salter A, Lynch S, et al
    Factors that influence adherence with disease-modifying therapy in MS.
    J Neurol. 2009;256:568-76.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
39. KOLAPPAN M , Henderson AP, Jenkins TM, Wheeler-Kingshott CA, et al
    Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis.
    J Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. TREMLETT H , Zhao Y, Devonshire V
    Natural history comparisons of primary and secondary progressive multiple sclerosis reveals differences and similarities.
    J Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. HUTCHINSON M , Kappos L, Calabresi PA, Confavreux C, et al
    The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL.
    J Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. HAYTON T , Furby J, Smith KJ, Altmann DR, et al
    Grey matter magnetization transfer ratio independently correlates with neurological deficit in secondary progressive multiple sclerosis.
    J Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. ROCCA MA , Gatti R, Agosta F, Broglia P, et al
    Influence of task complexity during coordinated hand and foot movements in MS patients with and without fatigue : A kinematic and functional MRI study.
    J Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. MORROW SA , Kaushik T, Zarevics P, Erlanger D, et al
    The effects of L: -amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial.
    J Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. CONTE A , Lenzi D, Frasca V, Gilio F, et al
    Intracortical excitability in patients with relapsing-remitting and secondary progressive multiple sclerosis.
    J Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. KRONE B , Oeffner F, Grange JM
    Is the risk of multiple sclerosis related to the 'biography' of the immune system?
    J Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. HUTTNER HB , Schellinger PD, Struffert T, Richter G, et al
    MRI criteria in MS patients with negative and positive oligoclonal bands: equal fulfillment of Barkhof's criteria but different lesion patterns.
    J Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
48. HELLWIG K , Agne H, Gold R
    Interferon beta, birth weight and pregnancy in multiple sclerosis.
    J Neurol. 2009.
    PubMed     Text format     Related articles   
    
    
    
49. FENOGLIO C , Scalabrini D, Piccio L, De Riz M, et al
    Candidate gene analysis of selectin cluster in patients with multiple sclerosis.
    J Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. STRUPP M
    Multiple sclerosis: the ongoing natalizumab story and more.
    J Neurol. 2009;256:293-5.
    PubMed     Text format     Related articles   
    
    
    
51. HOMMES OR , Haas J, Soelberg-Sorenson P, Friedrichs M, et al
    IVIG trials in MS. Is albumin a placebo?
    J Neurol. 2009;256:268-70.
    PubMed     Text format     Related articles   
    
    
    
52. BABA T , Nakashima I, Kanbayashi T, Konno M, et al
    Narcolepsy as an initial manifestation of neuromyelitis optica with anti-aquaporin-4 antibody.
    J Neurol. 2009;256:287-8.
    PubMed     Text format     Related articles   
    
    
    January 2009
53. CABRERA-GOMEZ JA , Kurtzke JF, Gonzalez-Quevedo A, Lara-Rodriguez R, et al
    An epidemiological study of neuromyelitis optica in Cuba.
    J Neurol. 2009;256:35-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
54. PAPATHANASOPOULOS P , Messinis L, Lyros E, Nikolakopoulou A, et al
    Communicating the diagnosis of multiple sclerosis : Results of a survey among Greek neurologists.
    J Neurol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. STRUPP M
    Multiple sclerosis: from new old monoclonal antibodies to disease markers.
    J Neurol. 2008;255:1990-2.
    PubMed     Text format     Related articles   
    
    
    November 2008
56. PACHNER AR , Brady J, Steiner I, Narayan K, et al
    Management of neutralizing antibodies against beta-IFN in beta-IFNtreated multiple sclerosis patients.
    J Neurol. 2008.
    PubMed     Text format     Related articles   
    
    
    
57. SIMIONI S , Ruffieux C, Kleeberg J, Bruggimann L, et al
    Preserved decision making ability in early multiple sclerosis.
    J Neurol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. KURNE A , Isikay IC, Karlioguz K, Kalyoncu U, et al
    A clinically isolated syndrome: A challenging entity : Multiple sclerosis or collagen tissue disorders: Clues for differentiation.
    J Neurol. 2008;255:1625-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
59. CUCURACHI L , Immovilli P, Granella F, Pavesi G, et al
    Short-latency afferent inhibition predicts verbal memory performance in patients with multiple sclerosis.
    J Neurol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. WIENDL H , Toyka KV, Rieckmann P, Gold R, et al
    Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations.
    J Neurol. 2008;255:1449-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. ARNOLD DL , Campagnolo D, Panitch H, Bar-Or A, et al
    Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MS.
    J Neurol. 2008;255:1473-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
62. SIGER M , Dziegielewski K, Jasek L, Bieniek M, et al
    Optical coherence tomography in multiple sclerosis : Thickness of the retinal nerve fiber layer as a potential measure of axonal loss and brain atrophy.
    J Neurol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. SCHMIERER K
    Commentary on: "Dirtyappearing white matter in multiple sclerosis : Preliminary observations of myelin phospholipid and axonal loss", by G. R. W. Moore, et al. in J Neurol (2008) 255: DOI 10.1007/s00415-008-0002-z.
    J Neurol. 2008.
    PubMed     Text format     Related articles   
    
    
    
64. MOORE GR , Laule C, Mackay A, Leung E, et al
    Dirty-appearing white matter in multiple sclerosis : Preliminary observations of myelin phospholipid and axonal loss.
    J Neurol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. DURELLI L , Barbero P, Bergui M, Versino E, et al
    The OPTimization of interferon for MS study: 375 microg interferon beta-1b in suboptimal responders.
    J Neurol. 2008;255:1315-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. MESAROS S , Rocca MA, Sormani MP, Charil A, et al
    Clinical and conventional MRI predictors of disability and brain atrophy accumulation in RRMS. A large scale, short-term follow-up study.
    J Neurol. 2008;255:1378-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. KAUT O , Klockgether T
    51-year-old female with steroid-responsive optic neuropathy: a new case of chronic relapsing inflammatory optic neuropathy (CRION).
    J Neurol. 2008;255:1419-20.
    PubMed     Text format     Related articles   
    
    
    July 2008
68. PATTI F , Cavallaro T, Lo Fermo S, Nicoletti A, et al
    Is in utero early-exposure to interferon beta a risk factor for pregnancy outcomes in multiple sclerosis?
    J Neurol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. PRESSLAUER S , Milosavljevic D, Brucke T, Bayer P, et al
    Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis.
    J Neurol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. LEUSSINK VI , Lehmann HC, Meyer Zu Horste G, Hartung HP, et al
    Rituximab induces clinical stabilization in a patient with fulminant multiple sclerosis not responding to natalizumab : Evidence for disease heterogeneity.
    J Neurol. 2008.
    PubMed     Text format     Related articles   
    
    
    
71. JULIAN LJ , Vella L, Vollmer T, Hadjimichael O, et al
    Employment in multiple sclerosis : Exiting and re-entering the work force.
    J Neurol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. HAUPTS MR , Schimrigk SK, Brune N, Chan A, et al
    Fulminant tumefactive multiple sclerosis: Therapeutic implications of histopathology.
    J Neurol. 2008.
    PubMed     Text format     Related articles   
    
    
    June 2008
73. RAMAGOPALAN SV , Deluca GC, Morrison KM, Herrera BM, et al
    Analysis of 45 candidate genes for disease modifying activity in multiple sclerosis.
    J Neurol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. YTTERBERG C , Johansson S, Andersson M, Widen Holmqvist L, et al
    Variations in functioning and disability in multiple sclerosis : A two-year prospective study.
    J Neurol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. MANDRIOLI J , Sola P, Bedin R, Gambini M, et al
    A multifactorial prognostic index in multiple sclerosis : Cerebrospinal fluid IgM oligoclonal bands and clinical features to predict the evolution of the disease.
    J Neurol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2008
76. SIEPMAN TA , Janssens AC, de Koning I, Polman CH, et al
    The role of disability and depression in cognitive functioning within 2 years after multiple sclerosis diagnosis.
    J Neurol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. COMABELLA M , Julia E, Tintore M, Brieva L, et al
    Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosis.
    J Neurol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. BENEDICT RH , Munschauer F, Zarevics P, Erlanger D, et al
    Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patients.
    J Neurol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. JOZEFOWICZ-KORCZYNSKA M , Lukomski M, Pajor A
    Identification of internuclear ophthalmoplegia signs in multiple sclerosis patients : Saccade test analysis.
    J Neurol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. WATTJES MP , Harzheim M, Lutterbey GG, Hojati F, et al
    Does high field MRI allow an earlier diagnosis of multiple sclerosis?
    J Neurol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. LJOSTAD U , Mygland A
    CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.
    J Neurol. 2008;255:732-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. RIVERA JF , Kurtzke JF, Booth VJ, Corona V T 5th, et al
    Characteristics of Devic's disease (neuromyelitis optica) in Mexico.
    J Neurol. 2008;255:710-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. ROCCA MA , Agosta F, Sormani MP, Fernando K, et al
    A three-year, multi-parametric MRI study in patients at presentation with CIS.
    J Neurol. 2008;255:683-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2008
84. HELLWIG K , Beste C, Brune N, Haghikia A, et al
    Increased MS relapse rate during assisted reproduction technique.
    J Neurol. 2008;255:592-3.
    PubMed     Text format     Related articles   
    
    
    
85. POLMAN C , Kappos L, Freedman MS, Edan G, et al
    Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b.
    J Neurol. 2008;255:480-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2008
86. RASHID W , Hadjiprocopis A, Davies G, Griffin C, et al
    Longitudinal evaluation of clinically early relapsing-remitting multiple sclerosis with diffusion tensor imaging.
    J Neurol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. THICKBROOM GW , Sacco P, Faulkner DL, Kermode AG, et al
    Enhanced corticomotor excitability with dynamic fatiguing exercise of the lower limb in multiple sclerosis.
    J Neurol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. BAUMHACKL U
    The search for a balance between short and long-term treatment outcomes in multiple sclerosis.
    J Neurol. 2008;255 Suppl 1:75-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. GOLD R
    Combination therapies in multiple sclerosis.
    J Neurol. 2008;255 Suppl 1:51-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. STADELMANN C , Bruck W
    Interplay between mechanisms of damage and repair in multiple sclerosis.
    J Neurol. 2008;255 Suppl 1:12-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. WEINER HL
    A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis.
    J Neurol. 2008;255 Suppl 1:3-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. ZIVADINOV R , Stosic M, Cox JL, Ramasamy DP, et al
    The place of conventional MRI and newly emerging MRI techniques in monitoring different aspects of treatment outcome.
    J Neurol. 2008;255 Suppl 1:61-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. COYLE PK
    Switching algorithms: from one immunomodulatory agent to another.
    J Neurol. 2008;255 Suppl 1:44-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. TINTORE M
    Rationale for early intervention with immunomodulatory treatments.
    J Neurol. 2008;255 Suppl 1:37-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. BLANCHETTE F , Neuhaus O
    Glatiramer acetate: evidence for a dual mechanism of action.
    J Neurol. 2008;255 Suppl 1:26-36.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. HILLERT J , Soelberg Sorensen P
    Editorial.
    J Neurol. 2008;255 Suppl 1:1-2.
    PubMed     Text format     Related articles   
    
    
    February 2008
97. BIRNBAUM T , Pellkofer H, Buettner U
    Intracranial germinoma clinically mimicking chronic progressive multiple sclerosis.
    J Neurol. 2008;.
    PubMed     Text format     Related articles   
    
    
    
98. GHAFFAR O , Chamelian L, Feinstein A
    Neuroanatomy of pseudobulbar affect : A quantitative MRI study in multiple sclerosis.
    J Neurol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. KISHIMOTO R , Yabe I, Niino M, Sato K, et al
    Balo's concentric sclerosislike lesion in the brainstem of a multiple sclerosis patient.
    J Neurol. 2008;.
    PubMed     Text format     Related articles   
    
    
    
100. PUGLIATTI M , Riise T, Nortvedt MW, Carpentras G, et al
     Self-perceived physical functioning and health status among fully ambulatory multiple sclerosis patients.
     J Neurol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. LORBERBOYM M , Lampl Y, Nikolov G, Sadeh M, et al
     I-123 MIBG cardiac scintigraphy and autonomic test evaluation in multiple sclerosis patients.
     J Neurol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. HIRST CL , Pace A, Pickersgill TP, Jones R, et al
     Campath 1-H treatment in patients with aggressive relapsing remitting multiple sclerosis.
     J Neurol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. DAHL J , Myhr KM, Daltveit AK, Gilhus NE, et al
     Pregnancy, delivery and birth outcome in different stages of maternal multiple sclerosis.
     J Neurol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. KIS B , Rumberg B, Berlit P
     Clinical characteristics of patients with late-onset multiple sclerosis.
     J Neurol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. GEURTS JJ , Blezer EL, Vrenken H, van der Toorn A, et al
     Does high-field MR imaging improve cortical lesion detection in multiple sclerosis?
     J Neurol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. NAKAMURA M , Miyazawa I, Fujihara K, Nakashima I, et al
     Preferential spinal central gray matter involvement in neuromyelitis optica. An MRI study.
     J Neurol. 2008;255:163-70.
     PubMed     Text format     Related articles    Abstract available
     
     
     
107. SHIMIZU Y , Yokoyama K, Misu T, Takahashi T, et al
     Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis.
     J Neurol. 2008;255:305-7.
     PubMed     Text format     Related articles   
     
     
     January 2008
108. CALABRESE M , De Stefano N, Atzori M, Bernardi V, et al
     Extensive cortical inflammation is associated with epilepsy in multiple sclerosis.
     J Neurol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. DEBOUVERIE M , Pittion-Vouyovitch S, Brissart H, Guillemin F, et al
     Physical dimension of fatigue correlated with disability change over time in patients with multiple sclerosis.
     J Neurol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. HIRST C , Ingram G, Pearson O, Pickersgill T, et al
     Contribution of relapses to disability in multiple sclerosis.
     J Neurol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
111. STRUPP M
     Inflammatory CNS disorders: use of dexamethasone in bacterial meningitis and new insights in multiple sclerosis.
     J Neurol. 2008;255:149-151.
     PubMed     Text format     Related articles   
     
     
     
112. PERUMAL J , Zabad R, Caon C, MacKenzie M, et al
     Acute transverse myelitis with normal brain MRI : long-term risk of MS.
     J Neurol. 2008;255:89-93.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. SEEWANN A , Enzinger C, Filippi M, Barkhof F, et al
     MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain : A review of reported findings.
     J Neurol. 2008;255:1-10.
     PubMed     Text format     Related articles    Abstract available
     
     
     November 2007
114. KHANNA S , Liao K, Kaminski HJ, Tomsak RL, et al
     Ocular myasthenia revisited: insights from pseudo-internuclear ophthalmoplegia.
     J Neurol. 2007;254:1569-74.
     PubMed     Text format     Related articles    Abstract available
     
     
     September 2007
115. SAIZ A , Zuliani L, Blanco Y, Tavolato B, et al
     Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients.
     J Neurol. 2007;254:1233-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     May 2007
116. KLAUER T , Schneider W, Zettl UK
     Coping with neuroimmunological diseases.
     J Neurol. 2007;254 Suppl 2:II107-11.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

This AMEDEO Service was made possible thanks to the generous unrestricted educational grants provided by Bayer Schering Pharma AG.

Amedeo is a Flying Publisher website.    Design: